IL-33 expression levels were determined by PCR and normalized to expression levels of GAPDH. The X-axis indicates months after CIS event in a cross-sectional study, N = 39. Each black dot represents the IL-33 expression in an individual patient and plotted against the time of blood draw to the date of the first clinical event of MS.</p
Background Alarmins are considered proximal mediators of the immune response after tissue injury. Un...
<p>Scatter diagram displaying the protein levels of IL-33 and sST2 in the plasma of HFRS patients. C...
<p>Expression levels of TLR1-10, MyD88, and MX1 mRNA were determined in PBMCs of 25 patients with RR...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
(a) Profile of IL-33 in patients showing highest level of expression of IL-33 at month 0, month 6–9 ...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
The Y axis shows the different therapies patients were maintained on during the 12 month period afte...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
Objectives: Interleukin (IL)-33 is a cytokine with both pro- and anti-inflammatory effects involved ...
<p>BALB/c mice were injected i.v. with 2x10<sup>5</sup> PFU of WT MCMV (MW97.01) and liver tissue wa...
Background Alarmins are considered proximal mediators of the immune response after tissue injury. Un...
<p>Scatter diagram displaying the protein levels of IL-33 and sST2 in the plasma of HFRS patients. C...
<p>Expression levels of TLR1-10, MyD88, and MX1 mRNA were determined in PBMCs of 25 patients with RR...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
(a) Profile of IL-33 in patients showing highest level of expression of IL-33 at month 0, month 6–9 ...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
The Y axis shows the different therapies patients were maintained on during the 12 month period afte...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
Objectives: Interleukin (IL)-33 is a cytokine with both pro- and anti-inflammatory effects involved ...
<p>BALB/c mice were injected i.v. with 2x10<sup>5</sup> PFU of WT MCMV (MW97.01) and liver tissue wa...
Background Alarmins are considered proximal mediators of the immune response after tissue injury. Un...
<p>Scatter diagram displaying the protein levels of IL-33 and sST2 in the plasma of HFRS patients. C...
<p>Expression levels of TLR1-10, MyD88, and MX1 mRNA were determined in PBMCs of 25 patients with RR...